| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/10/2011 | CA2772628A1 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | CA2772613A1 Anti-gitr antibodies |
| 03/10/2011 | CA2772567A1 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
| 03/10/2011 | CA2772469A1 Protein glycosylation |
| 03/10/2011 | CA2772372A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 03/10/2011 | CA2770070A1 Heterologous prime-boost immunization regimen against bluetongue virus |
| 03/09/2011 | EP2293075A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293074A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2292802A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/09/2011 | EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
| 03/09/2011 | EP2292666A2 Neoplasm specific antibodies and uses thereof |
| 03/09/2011 | EP2292665A1 Use of interleukin-4 antagonists and compositions thereof |
| 03/09/2011 | EP2292664A2 Multispecific deimmunized CD3-binders |
| 03/09/2011 | EP2292663A2 Antagonistic human light-specific human monoclonal antibodies |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292659A1 Anti-perspiration antigen monoclonal antibody |
| 03/09/2011 | EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 03/09/2011 | EP2292643A1 Replikin peptides and uses thereof |
| 03/09/2011 | EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production |
| 03/09/2011 | EP2292632A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/09/2011 | EP2292631A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 03/09/2011 | EP2292301A2 Anti-interferon-alpha antibodies |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292266A1 Treating cancer by modulating copine III |
| 03/09/2011 | EP2292265A1 Set of antiangiogenic molecules and use thereof |
| 03/09/2011 | EP2292264A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| 03/09/2011 | EP2292263A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 03/09/2011 | EP2292262A2 Use of modified novirhabdoviruses to obtain vaccines |
| 03/09/2011 | EP2292261A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 03/09/2011 | EP2292260A1 Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis |
| 03/09/2011 | EP2292259A2 Complement receptor 2 targeted complement modulators |
| 03/09/2011 | EP2292258A1 Multiepitope vaccine for Her2/neu-associated cancers |
| 03/09/2011 | EP2292251A1 Combination therapy using anti-angiogenic agents and TNF-alpha |
| 03/09/2011 | EP2292250A1 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus |
| 03/09/2011 | EP2292248A2 Anti-angiogenic compounds |
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 03/09/2011 | EP2292233A2 Pharmaceutical uses of N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine |
| 03/09/2011 | EP2292097A2 Recombinant parainfluenza virus expression systems and vaccines |
| 03/09/2011 | EP2291406A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/09/2011 | EP2291405A1 ANTI-PirB ANTIBODIES |
| 03/09/2011 | EP2291404A1 Antibodies to il-6 and their uses |
| 03/09/2011 | EP2291403A1 Treatment of chronic prostatitis |
| 03/09/2011 | EP2291402A2 Antibodies against domains of laminin-332 |
| 03/09/2011 | EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 03/09/2011 | EP2291398A1 Her3 as a determinant for the prognosis of melanoma |
| 03/09/2011 | EP2291394A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 03/09/2011 | EP2291335A1 Anticorrosive composition |
| 03/09/2011 | EP2291196A2 Staphylococcus aureus-specific antibody preparations |
| 03/09/2011 | EP2291195A1 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
| 03/09/2011 | EP2291194A1 Compositions and methods for enhanced somatostatin immunogenicity |
| 03/09/2011 | EP2291190A2 Vaccine composition containing synthetic adjuvant |
| 03/09/2011 | EP2291086A1 Fermentation process |
| 03/09/2011 | EP1899462B1 Stable aqueous systems comprising proteins |
| 03/09/2011 | EP1749029B1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2011 | EP1732602B1 Detecting the mcsp-surface expression of a cell |
| 03/09/2011 | EP1709177B1 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 03/09/2011 | EP1709080B1 ANTIBODIES TO MAdCAM |
| 03/09/2011 | EP1708961B1 Anti-ip-10 antibodies |
| 03/09/2011 | EP1596880B1 Methods and compositions for suppressing fibrocyte differentiation |
| 03/09/2011 | EP1594548B1 Anthracycline-anti-cd74 antibody conjugates |
| 03/09/2011 | EP1583558B1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 03/09/2011 | EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 03/09/2011 | EP1181320B1 Somatic transgene immunization and related methods |
| 03/09/2011 | EP0994949B1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 03/09/2011 | CN101984061A Vaccine strains of infectious clones of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
| 03/08/2011 | US7902350 Method for monitoring the efficacy of a Mycobacterium avium subspecies paratuberculosis therapy |
| 03/08/2011 | US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) |
| 03/08/2011 | US7902348 Janus family kinases and identification of immune modulators |
| 03/08/2011 | US7902344 Nucleotide sequences coding antibody specific for bacillus anthracis antigen for use in diagnosis, prevention and treatment of anthrax exposure; immunotherapy |
| 03/08/2011 | US7902328 Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 03/08/2011 | US7902151 Methods and compositions for modulating immunity |
| 03/08/2011 | US7901921 Viral purification methods |
| 03/08/2011 | US7901920 Virosome-like-particles |
| 03/08/2011 | US7901907 Process for production of Helicobacter pylori bacterioferritin |
| 03/08/2011 | US7901693 Compositions and methods for WT1 specific immunotherapy |
| 03/08/2011 | US7901692 Nontypeable Haemophilus influenzae virulence factors |
| 03/08/2011 | US7901691 Chimeric G protein based rabies vaccine |
| 03/08/2011 | US7901690 Comprised of different nucleic acid sequences from distinct genetic clades; reduced mutation efficacy loss |
| 03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 03/08/2011 | US7901688 Rage fusion proteins |
| 03/08/2011 | US7901687 Antibodies for the detection of Bacillus anthracis and vaccine against B. anthracis infections |
| 03/08/2011 | US7901686 drug screening; reaction mixture includes a hedgehog polypeptide, a patched polypeptide, and a test compound; receptor binding assay |
| 03/08/2011 | US7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/08/2011 | US7901684 Antibodies against human IL-22 and uses therefor |
| 03/08/2011 | US7901683 Methods of inhibiting amyloid toxicity |
| 03/08/2011 | US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 03/08/2011 | US7901681 Trypanosome derived apoptotic factors (TAF) |
| 03/08/2011 | US7901680 Dock-and-lock (DNL) vaccines for cancer therapy |
| 03/08/2011 | US7901679 Humanized anti-ghrelin antibodies |
| 03/08/2011 | US7901678 Medicinal compositions containing Fc receptor γ chain activator |
| 03/08/2011 | US7901677 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types |
| 03/08/2011 | US7901676 Therapeutic composition for the treatment of rheumatoid arthritis |
| 03/08/2011 | CA2329054C A novel polypeptide hormone phosphatonin |
| 03/03/2011 | WO2011026111A1 Oral delivery of a vaccine to the large intestine to induce mucosal immunity |
| 03/03/2011 | WO2011026031A1 Antibodies that bind tau oligomers |
| 03/03/2011 | WO2011026026A1 Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity |
| 03/03/2011 | WO2011026000A1 Cofactors for thrombin activation of factor vii and uses thereof |
| 03/03/2011 | WO2011025978A2 Methods of treatment using anti-oxidized ldl antibodies |
| 03/03/2011 | WO2011025904A1 Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof |